Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes

References

• Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004;328:915–19
   PubMed Web of Science ®Google Scholar
• Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004;27:2819–23
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Vaz JA. Insulin treatment in diabetic pregnancy. Diabetes Metab Res Rev 2008;24:S3–20
   PubMed Web of Science ®Google Scholar
• Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008;31:9–14
   PubMed Web of Science ®Google Scholar
• Colquitt JL, Green C, Sidhu MK, et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004;8:iii, 1–171
   Google Scholar
• Fatourechi MM, Kudva YC, Murad MH, et al. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2008;94:729–40
   Google Scholar
• Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007;3:CD005542
   Google Scholar
• Giménez M, Conget I, Nicolau J, et al. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetol 2007;44:34–7
   PubMed Web of Science ®Google Scholar
• Chico A, Saigi I, García-Patterson A, et al. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin. Diabetes Technol Ther 2010;12:937–45
   PubMed Web of Science ®Google Scholar
• Cyganek K, Hebda-Szydlo A, Katra B, et al. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol Ther 2010;12:41–7
   PubMed Web of Science ®Google Scholar
• Bruttomesso D, Bonomo M, Costa S, et al. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). Diabetes Metabol 2011;37:426–31
   PubMed Web of Science ®Google Scholar
• Wender-Ozegowska E, Zawiejska A, Ozegowska K, et al. Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes. Aust N Z J Obstet Gynaecol 2013;53:130–5
   PubMed Web of Science ®Google Scholar
• Zisser H, Robinson L, Bevier W, et al. Bolus calculator: a review of four “Smart” insulin pumps. Diabetes Technol Ther 2008;10:441–4
   Google Scholar
• Cukierman-Yaffe T, Konvalina N, Cohen O. Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes. Diabetes Res Clin Pract 2011;92:69–73
   Google Scholar
• Walsh J, Roberts R, Bailey T. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol 2010;4:1174–81
   Google Scholar
• García-Patterson A, Gich I, Amini SB, et al. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia 2009;53:446–51
   Google Scholar
• Secher AL, Ringholm L, Andersen HU, et al. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care 2013;36:1877–83
   PubMed Web of Science ®Google Scholar
• Nielsen LR, Ekbom P, Damm P, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004;27:1200–1
   PubMed Web of Science ®Google Scholar
• Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245–9
   PubMed Web of Science ®Google Scholar
• Marsál K, Persson PH, Larsen T, et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843–8
   PubMed Web of Science ®Google Scholar
• Roeder HA, Moore TR, Ramos GA. Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitus. Am J Obstet Gynecol 2012;207:324.e1–5
   Google Scholar
• Murphy HR, Kumareswaran K, Elleri D, et al. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care 2011;34:2527–9
   PubMed Web of Science ®Google Scholar
• Murphy HR, Elleri D, Allen JM, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia 2011;55:282–93
   Google Scholar
• Castorino K, Paband R, Zisser H, Jovanovic L. Insulin pumps in pregnancy: using technology to achieve normoglycemia in women with diabetes. Curr Diab Rep 2011;12:53–9
   Google Scholar
• Hermansen K, Bendtson I, Borch-Johnsen K, et al. Insulin pump treatment in Denmark. Ugeskr Laeg 2004;166:3685–9
   Google Scholar